Products Categories
| CAS No.: | 37270-71-6 |
|---|---|
| Name: | Modicon |
| Molecular Structure: | |
|
|
|
| Formula: | C20H26O2•C20H24O2 |
| Molecular Weight: | 594.90 |
| Synonyms: | Modicon |
| Density: | g/cm3 |
| Boiling Point: | 447°Cat760mmHg |
| Flash Point: | 190.5°C |
| Safety: | Human teratogenic effects by an unspecified route: developmental abnormalities of the urogenital system. Human systemic effects by ingestion: dyspnea, nausea or vomiting, and fever. Experimental reproductive effects. Questionable human carcinogen producing liver tumors. Mutation data reported. A steroid. When heated to decomposition it emits acrid smoke and irritating fumes. |
| PSA: | 77.76000 |
| LogP: | 7.10510 |
- 483366-12-7(2S,4R)-1-Boc-2-cyano-4-hydroxypyrrolidine
- 5156-58-1N-(1-Benzyl-4-pipperidinyl)-N-phenylpropanamide HCl
- 81281-59-67-Benzylideneaminotheophylline
- 50288-62-5threo-Phenyl-2-piperidyl acetamide
- 82993-81-5D-threo-Ritalinic acid hydrochloride
- 47087-37-6Z-D-Glu-OMe
- 73441-42-6METHYL-5-CHLORO-2,2-DIMETHYLVALERATE
- 68439-39-4Poly(oxy-1,2-ethanediyl), alpha-(2-ethylhexyl)-omega-hydroxy-,
- 852475-26-4MC1568
- 43224-75-52,2,6,6-Tetramethyl-4-(2-propyleneoxy) Piperidine
- Total:3 Page 1 of 1 1
What can I do for you?
Get Best Price
Chemistry
Product Name: Ethynylestradiol mixture with norethindrone (CAS NO.37270-71-6)
Molecular Formula: C40H50O4
Molecular Weight: 594.90g/mol
Mol File: 37270-71-6.mol
Boiling point: 447 °C at 760 mmHg
Flash Point: 190.5 °C
Enthalpy of Vaporization: 81.38 kJ/mol
Vapour Pressure: 7.22E-10 mmHg at 25°C
H-Bond Donor: 3
H-Bond Acceptor: 4
Structure Descriptors of Ethynylestradiol mixture with norethindrone (CAS NO.37270-71-6):
IUPAC Name: (8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one;(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
Toxicity Data With Reference
| 1. | oms-ctl:oth 17,410 µg/L | AJOGAH American Journal of Obstetrics and Gynecology. 120 (1974),390. | ||
| 2. | oms-dom:oth 17,410 µg/L | AJOGAH American Journal of Obstetrics and Gynecology. 120 (1974),390. | ||
| 3. | oms-mam:oth 10,100 µg/L | AJOGAH American Journal of Obstetrics and Gynecology. 120 (1974),390. | ||
| 4. | orl-wmn TDLo:138 mg/kg/9Y-I:CAR,LIV | LANCAO Lancet. 1 (1980),273. | ||
| 5. | orl-wmn TD:138 mg/kg/9Y-I:CAR,LIV | BMJOAE British Medical Journal. 4 (1975),496. | ||
| 6. | orl-wmn TDLo:55 mg/kg/5Y-I:PUL,GIT,MET | LANCAO Lancet. 1 (1973),1479. |
Safety Profile
Human teratogenic effects by an unspecified route: developmental abnormalities of the urogenital system. Human systemic effects by ingestion: dyspnea, nausea or vomiting, and fever. Experimental reproductive effects. Questionable human carcinogen producing liver tumors. Mutation data reported. A steroid. When heated to decomposition it emits acrid smoke and irritating fumes.
Specification
Ethynylestradiol mixture with norethindrone , its CAS NO. is 37270-71-6, the synonyms are Aranelle ; Balziva ; Duagynon ; E-Con ; Ethinylestradiol-norethisterone mixt. ; Eve 20 ; Femcon Fe ; Gencept 10/11-21 ; Gynovlar ; Norethindron-ethinylestradiol mixt. ; Norethindrone Ethinyl Estradiol ; Norethindrone and ethinyl estradiol ; Norethisterone-ethinylestradiol mixt. ; Norimin ; Trinovum ; (17alpha)-17-Hydroxy-19-norpregn-4-en-20-yn-3-one, mixture with (17alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol ; 19-Nor-17-alpha-pregn-4-en-20-yn-3-one, 17-hydroxy-, mixed with 19-nor-17-alpha-pregna-1,3,5(10)-trien-20-yne-3,17-diol .